
Conformis CFMS
Quarterly report 2023-Q2
added 08-02-2023
Conformis DPO Ratio 2011-2026 | CFMS
Annual DPO Ratio Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.4 | 61.3 | 51.2 | 62.1 | 30.4 | 36.2 | 37.6 | 40.6 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.1 | 30.4 | 46.2 |
Quarterly DPO Ratio Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.6 | 49.1 | - | 70.2 | 57.2 | 54.5 | - | 55.8 | 51.6 | 59.1 | - | 53.2 | 53.1 | 58.3 | - | 65.3 | 63.3 | 43.7 | - | 33.9 | 31.5 | 35 | - | 40.2 | 36.5 | 33.9 | - | 39.5 | 37.5 | 34.2 | - | 38.7 | 37.8 | 40.5 | - | 44.9 | 23.3 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 70.2 | 23.3 | 45.5 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.42 | -2.43 % | $ 128 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.96 | -0.95 % | $ 1.62 B | ||
|
FONAR Corporation
FONR
|
16.6 | $ 18.59 | -0.08 % | $ 122 M | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
ClearPoint Neuro
CLPT
|
33.2 | $ 9.14 | -2.56 % | $ 259 M | ||
|
Globus Medical
GMED
|
33.1 | $ 90.44 | 2.08 % | $ 12.2 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
46.4 | $ 36.34 | -1.09 % | $ 5.42 K | ||
|
Helius Medical Technologies
HSDT
|
362 | $ 1.79 | -5.79 % | $ 1.09 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.29 | -0.21 % | $ 715 M | ||
|
Inspire Medical Systems
INSP
|
103 | $ 54.5 | 0.66 % | $ 1.6 B | ||
|
IRIDEX Corporation
IRIX
|
71.9 | $ 1.0 | 0.34 % | $ 16.9 M | ||
|
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.22 | -0.48 % | $ 2.96 B | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.7 | -1.54 % | $ 368 M | ||
|
LENSAR
LNSR
|
146 | $ 5.83 | -1.1 % | $ 69.7 M | ||
|
Medtronic PLC
MDT
|
76.2 | $ 86.5 | 0.25 % | $ 111 B | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
Myomo
MYO
|
34.8 | $ 0.67 | -5.3 % | $ 28 M | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
33.7 | $ 167.2 | -2.72 % | $ 12.5 B | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
Orthofix Medical
OFIX
|
76.3 | $ 11.72 | -0.4 % | $ 464 M | ||
|
AxoGen
AXGN
|
34.4 | $ 30.54 | -6.43 % | $ 1.41 B | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
Insulet Corporation
PODD
|
22.5 | $ 204.83 | 0.65 % | $ 14.4 B | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
223 | $ 2.63 | 3.95 % | $ 7.29 M | ||
|
Butterfly Network
BFLY
|
51.3 | $ 4.0 | -3.27 % | $ 847 M | ||
|
Smith & Nephew plc
SNN
|
232 | $ 31.7 | -2.85 % | $ 23.8 B | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
70.1 | $ 331.21 | -0.33 % | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
24.4 | $ 24.24 | -1.38 % | $ 554 M | ||
|
Cytosorbents Corporation
CTSO
|
107 | $ 0.6 | 1.68 % | $ 37.3 M | ||
|
TELA Bio
TELA
|
31.8 | $ 0.68 | 7.69 % | $ 31.9 M | ||
|
TransMedics Group
TMDX
|
15.5 | $ 107.12 | 2.21 % | $ 3.64 B | ||
|
Tandem Diabetes Care
TNDM
|
35.7 | $ 18.93 | -1.28 % | $ 1.29 B | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
56 | $ 9.66 | -0.41 % | $ 346 M | ||
|
Boston Scientific Corporation
BSX
|
61.7 | $ 61.25 | -2.14 % | $ 90.7 B | ||
|
Alphatec Holdings
ATEC
|
73.8 | $ 11.14 | 1.55 % | $ 1.67 B |